Compile Data Set for Download or QSAR
Report error Found 1271 Enz. Inhib. hit(s) with Target = 'Epidermal growth factor receptor [T790M,L858R]'
TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM313222(N-[3-[[2-[4-(4-ethylpiperazin-1-yl)anilino]-5-(tri...)
Affinity DataKd:  0.0370nMAssay Description:Kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 ph...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200809(US9670231, 2.6)
Affinity DataIC50: 0.0760nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200810(US9670231, 2.7)
Affinity DataIC50: 0.0840nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM199995(US9670231, 1.34 | US9670231, 1.3)
Affinity DataIC50: 0.0880nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM199967(BDBM200762 | US9670231, 1.1)
Affinity DataIC50: 0.100nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765138(US12391671, Compound 022)
Affinity DataIC50: 0.100nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200795(US9670231, 1.75)
Affinity DataIC50: 0.180nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536921(US11896597, Compound 46)
Affinity DataIC50: 0.200nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200793(US9670231, 1.74)
Affinity DataIC50: 0.200nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536896(US11896597, Compound 21)
Affinity DataIC50: 0.200nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765227(US12391671, Compound 116)
Affinity DataIC50: 0.200nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200336(US9670231, 1.12)
Affinity DataIC50: 0.210nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200548(US9670231, 1.51)
Affinity DataIC50: 0.210nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200800(US9670231, 2.1)
Affinity DataIC50: 0.25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM313223(N-[3-[[2-[4-(4-ethylpiperazin-1-yl)-2-methoxy-anil...)
Affinity DataKd:  0.280nMAssay Description:Kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 ph...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM495017(US10994015, Example 313 | US10994015, Example 314)
Affinity DataIC50: 0.290nMAssay Description:All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536892(US11896597, Compound 17)
Affinity DataIC50: 0.300nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200501(US9670231, 1.29)
Affinity DataIC50: 0.300nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM528566(US11896597, Compound 37 | US11896597, Compound 12)
Affinity DataIC50: 0.300nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50555575(Lazertinib | Yh25448 | C-18112003-G | GNS-1480 | G...)
Affinity DataIC50: 0.300nMAssay Description:WT EGFR and EGFR [L858R/T790M] kinase assay: WT EGFR or EGFR [L858R/T790M] kinase was mixed with different concentrations of pre-diluted compounds fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM518642(US11896597, Compound 11)
Affinity DataIC50: 0.300nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536918(US11896597, Compound 43)
Affinity DataIC50: 0.300nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50555575(Lazertinib | Yh25448 | C-18112003-G | GNS-1480 | G...)
Affinity DataIC50: 0.300nMAssay Description:WT EGFR and EGFR [L858R/T790M] kinase assay: WT EGFR or EGFR [L858R/T790M] kinase was mixed with different concentrations of pre-diluted compounds fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536980(US11896597, Compound 95)
Affinity DataIC50: 0.300nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50555575(Lazertinib | Yh25448 | C-18112003-G | GNS-1480 | G...)
Affinity DataIC50: 0.300nMAssay Description:WT EGFR and EGFR [L858R/T790M] kinase assay: WT EGFR or EGFR [L858R/T790M] kinase was mixed with different concentrations of pre-diluted compounds fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200218(US9670231, 1.9)
Affinity DataIC50: 0.300nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50555575(Lazertinib | Yh25448 | C-18112003-G | GNS-1480 | G...)
Affinity DataIC50: 0.300nMAssay Description:WT EGFR and EGFR [L858R/T790M] kinase assay: WT EGFR or EGFR [L858R/T790M] kinase was mixed with different concentrations of pre-diluted compounds fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765131(2-[(5-Fluoro-2-hydroxy-phenyl)- (3H-imidazo[4,5-b]...)
Affinity DataIC50: 0.300nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765147(2-[1H-benzimidazol-2-yl-(5-fluoro-2-hydroxy-phenyl...)
Affinity DataIC50: 0.300nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50555575(Lazertinib | Yh25448 | C-18112003-G | GNS-1480 | G...)
Affinity DataIC50: 0.300nMAssay Description:WT EGFR and EGFR [L858R/T790M] kinase assay: WT EGFR or EGFR [L858R/T790M] kinase was mixed with different concentrations of pre-diluted compounds fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536961(US11896597, Compound 78)
Affinity DataIC50: 0.300nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50555575(Lazertinib | Yh25448 | C-18112003-G | GNS-1480 | G...)
Affinity DataIC50: 0.300nMAssay Description:WT EGFR and EGFR [L858R/T790M] kinase assay: WT EGFR or EGFR [L858R/T790M] kinase was mixed with different concentrations of pre-diluted compounds fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536920(US11896597, Compound 45)
Affinity DataIC50: 0.300nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536922(US11896597, Compound 47)
Affinity DataIC50: 0.300nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765143(US12391671, Compound 028)
Affinity DataIC50: 0.300nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765124(596.3 | US12391671, Compound 007)
Affinity DataIC50: 0.400nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM507755(US11896597, Compound 22 | US11896597, Compound 4)
Affinity DataIC50: 0.400nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765126(3-((1H-benzo[d]imidazol-2-yl)(5-fluoro-2-hydroxyph...)
Affinity DataIC50: 0.400nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536923(US11896597, Compound 48)
Affinity DataIC50: 0.400nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536941(US11896597, Compound 68 | US11896597, Compound 61)
Affinity DataIC50: 0.400nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200584(US9670231, 1.55)
Affinity DataIC50: 0.400nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536957(US11896597, Compound 74)
Affinity DataIC50: 0.400nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536943(US11896597, Compound 63)
Affinity DataIC50: 0.400nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536932(US11896597, Compound 57)
Affinity DataIC50: 0.400nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536982(US11896597, Compound 96)
Affinity DataIC50: 0.400nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765121(3-((1H-Benzo[d]imidazol-2-yl)(5- fluoro-2-hydroxyp...)
Affinity DataIC50: 0.400nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM743993(US12312329, Example T-1)
Affinity DataIC50: 0.400nMAssay Description:WT EGFR and EGFR[L858R/T790M] kinase detection: In 5× kinase buffer A, WT EGFR or EGFR[L858R/T790M] kinase was mixed with different concentrations of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765118(3-[1H-Benzimidazol-2-yl-(5-fluoro-2-hydroxy- pheny...)
Affinity DataIC50: 0.400nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765134(2-[1H-Benzimidazol-2-yl-(5-fluoro- 2-hydroxy-pheny...)
Affinity DataIC50: 0.400nMAssay Description:EGFR biochemical activity measurements were carried out using the homogeneous time-resolved fluorescence (HTRF) assay (Cisbio), inhibitors and DMSO n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM536907(US11896597, Compound 32)
Affinity DataIC50: 0.400nMAssay Description:The inhibition activity and the selectivity of the compounds against mutant EGFR and WT EGFR were assessed by using WT EGFR cell line A-431 (American...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/17/2024
Entry Details
US Patent

Displayed 1 to 50 (of 1271 total ) | Next | Last >>
Jump to: